Heartsciences to participate at the inaugural ef hutton global conference

Southlake, texas, may 08, 2023 (globe newswire) -- heart test laboratories, inc.  d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-based medical technology company focused on transforming ecgs/ekgs to save lives through the early  detection of heart disease, today announces that ceo, andrew simpson, will participate at the inaugural ef hutton global conference being held may 10 – 11, 2023, at the plaza hotel in new york city.
HSCS Ratings Summary
HSCS Quant Ranking